Ralliant (NYSE:RAL) Hits New 52-Week High – Here’s What Happened

Ralliant Corporation (NYSE:RAL)’s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $67.01 and last traded at $67.58, with a volume of 1176914 shares changing hands. The stock had previously closed at $66.08.

Analysts Set New Price Targets

RAL has been the topic of several recent analyst reports. Wall Street Zen downgraded shares of Ralliant from a “buy” rating to a “hold” rating in a research note on Sunday, May 31st. Citigroup lifted their price target on Ralliant from $51.00 to $70.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Truist Financial reaffirmed a “buy” rating and issued a $68.00 price target (up from $53.00) on shares of Ralliant in a report on Wednesday, May 13th. Vertical Research cut Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target for the company. in a report on Wednesday, May 27th. Finally, Zacks Research raised Ralliant from a “strong sell” rating to a “hold” rating in a report on Monday, April 13th. Seven research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $67.30.

Ralliant Stock Up 2.6%

The firm has a fifty day simple moving average of $53.04 and a 200-day simple moving average of $49.85. The firm has a market cap of $7.59 billion and a price-to-earnings ratio of -6.20. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.05 and a current ratio of 1.61.

Ralliant (NYSE:RAL) last posted its quarterly earnings data on Tuesday, May 12th. The company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.08. The firm had revenue of $534.60 million for the quarter. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The company’s revenue for the quarter was up 11.0% on a year-over-year basis. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. As a group, sell-side analysts expect that Ralliant Corporation will post 2.64 EPS for the current year.

Ralliant Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 23rd. Shareholders of record on Monday, June 8th will be given a dividend of $0.05 per share. The ex-dividend date is Monday, June 8th. This represents a $0.20 annualized dividend and a yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is presently -1.83%.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in RAL. Danske Bank A S bought a new position in Ralliant during the 4th quarter worth $25,000. V Square Quantitative Management LLC bought a new position in shares of Ralliant in the fourth quarter worth $26,000. Allworth Financial LP increased its position in shares of Ralliant by 134.4% in the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after purchasing an additional 293 shares during the period. Palisade Asset Management LLC bought a new position in shares of Ralliant in the third quarter worth $26,000. Finally, BOKF NA bought a new position in shares of Ralliant in the third quarter worth $29,000.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.